InMode Ltd. is rated a Strong Buy due to its robust balance sheet, proprietary technology, and international growth. Learn more about INMD stock here.

Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...

Q2 2026 Financial Highlights (3 Months Ended December 31, 2025): Revenue was $7.4 million, a quarterly record, compared to $4.5 million in the same quarter of the previous fiscal year, representing ...

Bladder cancer frequently announces itself through symptoms that patients dismiss as minor urinary issues, and that delay ...

Join Marissa Fayer, CEO of HerHealthEQ and DeepLook Medical, as she explores the future of women's health and what it could ...

Danaher , a $150 billion U.S. company that makes tools used in developing and testing medicines, on Tuesday agreed to buy Masimo for $9.9 billion, expanding in patient-monitoring devices in a surprise ...

Explore the OC-PAM AI tool that revolutionizes cancer research with non-invasive imaging of organoids and spheroids.

Community-based services promote healing, recovery, and revitalization for Southwest Florida residents Our focus is not ...

MyMichigan Medical Center Alpena recently received approval from the Michigan Department of Health and Human Services (MDHHS) ...

Merge Labs’ launch, backed by OpenAI and supported by scalable infrastructures like AI.cc, represents a pivotal moment in the journey toward true human-AI symbiosis. It moves the conversation from ...

Market set for 11.6% CAGR driven by sustainability push and circular economy adoption in medical device manufacturing - ...

MemorialCare Heart & Vascular Institute at Orange Coast Medical Center has earned national recognition for its Cardiovascular Rehabilitation Program, receiving certification from the American ...